Introduction
AIDS/HIV has become a worldwide epidemic, affecting different populations and geographic areas and has become the most important public health problem (Geo et al., 2013 ). An estimated 36.7 million people were infected with HIV, globally, in 2015, out of which 2.1 million were new infections. People living with HIV accounted for 1.2 million (11%) of all new TB cases worldwide. India has been reported to be in the 0-4.9% zone of HIV prevalence in new TB cases. Globally in 2015, 55% of notified TB patients (3.4 million) had a documented HIV test result, an 18-fold increase in testing coverage since 2004 (Global Tuberculosis Report, 2015 . According to sentinel surveillance held in 2014-2015 in India, HIV prevalence was 0.26%. Adult HIV prevalence for males was 0.30% and that of females was 0.22%.The most common age group affected was 15-49 years (National AIDS Control Organisation, 2015) HIV mainly affects the CD4 cell count, as the infection progresses, the CD4cell count declines. These cells play a major role in body defense against various opportunistic infections, of which the most common is Tuberculosis (TB) (Sameer et al., 2011 HIV/AIDS is a serious life threatening disease. The interaction of TB & HIV is two-fold, with TB being the leading cause of death among HIV infected patients. A decrease in CD4 count in HIV-TB co-infection, leads to an increase in morbidity and mortality. So this study was done to evaluate the CD4 cell count and its associating factors in HIV-TB co infection to estimate their immune status. This was a retrospective study, conducted in Jawahar Lal Nehru Medical College & associated group of Hospitals, Ajmer, Rajasthan, India. A total of 289 HIV-TB co-infected patients attending ART centre, from January 2015 to December 2016 were enrolled in this study. CD4 count was done by BD FACS count. Statistical analysis was performed with the SPSS. A total of 289 HIV/AIDS seropositive cases on ART having co-infection of TB were included in the study. In our study EPTB patients160 (55.36%) were higher in number as compared to PTB patients106 (44.64%). In majority of cases CD4 count was <200cells/µl which were 171 (59.17). A significant correlation was observed with age & CD4 count. Extra-pulmonary & sputum negative pulmonary HIV-TB patients outnumbered the sputum positive HIV-TB coinfected patients, which concludes that a newer & better test is required.
K e y w o r d s
CD4 count, extra-pulmonary TB, pulmonary TB, HIV. (Global Tuberculosis Report, 2015) . Approximately 60-80% of HIV-TB coinfected patients have pulmonary Tuberculosis (PTB), and 30-40% have extra pulmonary TB (EPTB). As the infection progresses there is advanced immunesuppression in HIV-infected persons & incidence of EPTB rises (Fauci et al., 2015) .
HIV-TB co-infection is one of the most health challenging issues worldwide, especially in developing countries like India. HIV-TB coinfection is associated with special diagnostic and therapeutic challenges and constitutes an immense burden on healthcare systems. Globally, HIV is threatening the control of TB. Treatment of co-infection with HIV and TB requires commitment and a focused approach. Appropriate use of antiretroviral drugs to treat HIV infection and ensuring high levels of coverage and compliance is required to prevent TB by preserving immunity.
Against this background, the present study was aimed at evaluation of CD4 cell count and its associating factors in HIV-TB (Pulmonary and extra-pulmonary) co infection to estimate their immune status.
Materials and Methods
This was a hospital based observational, descriptive & retrospective type of study conducted on a total of 289 HIV-TB coinfected patients in ART centre of JLN Medical College & associated group of Hospitals, Ajmer. The two year data was collected from January 2015 to December 2016 of the HIV-TB co-infected patients. The patients on ART were included in the study. 
Statistical Analysis
Statistical analysis was performed with the SPSS, Trial version 23 for Windows statistical software package (SPSS inc., Chicago, il, USA) and Primer. The Categorical data were presented as numbers (percent) and were compared among groups using Chi square test. The quantitative data were presented as mean and standard deviation and were compared using by students t-test and ANOVA Test and post Hoc Test Turkey Test applying to find out the most significant groups among all the groups. P value <0.05 was considered statistically significant.
Results and Discussion
The total study population was 289 cases in two years of duration. In year 2014 -15, 144 (49.83%) and in Year 2015 -16, 145 (50.17 %) cases attended the hospital. The most common age group of HIV TB co-infection was >40 year (35.64%) followed by 30-39 Years 94(32.53%). Males outnumbered the females (77.16% vs 22.84%). According to CD4 cell Count, 171(59.17%) cases were in range of less than and equal to 200 cells/l of CD4 count. Only 27 (9.34%) cases, were ≥500 cells/l CD4 cell Count. (Table no 1 ).In our study maximum patients had EPTB which were 160(55.36%) which was followed by SP-TB 106 (36.68%) (Figure no .1) Association of Age and CD4 cell count with HIV-TB co-infection status was statistically significant (Table no 2 ).
In our study CD4 cell count was significantly less than 200 cells/µl in older age groups as compared to younger age group in which the CD4 cell count was greater than 500 cells/µl. No significant association with gender was observed (P=0.076NS). There was no significant association was observed with CD4 cell count with type of TB infection (Table no 2 ).
In our result we observed a higher number of patients whose had CD4 cell count <200 cells/µl were Extra-pulmonary TB 98 (61.25%) as compared to the Pulmonary TB cases 73 (56.58%). The Mean CD4 cell count in Sputum negative cases was 252. The harmful association between the HIV and tuberculosis epidemics has added dramatically to the suffering and death caused by each disease alone. HIV/AIDS affects mainly the CD4 cell count, as there is decrease in the cell count the chances of opportunistic infection increases. The most common opportunistic infection in AIDS is TB. The HIV-TB co-infection is the emerging threat and most health challenging issues globally.
This study was done on 289 HIV-TB coinfected patients. The most common age group of HIV TB co-infection was >40 year 103(35.64%). Our finding were similar to Siddeswari et al., (2016) in which there were 37.50% cases, whereas Mihir Bhattacharya et al., (2011) reported slightly higher number of cases in which there were 45% cases affected in the same age group. This may be due to the fact, that, as the age progresses the immunity decreases (Mihir et al., 2011; Siddeswari et al., 2016) . In this study males were affected more than females which was 223(77.16%). Ketki Jangid et al., (2015 ) & Amara Ezeamama et al., (2015 also reported males to be in higher number which were 81.25% & 57% respectively. This may be because of the reason that the male has to migrate for occupation and stay away from spouse for a longer period. Yasmin et al., (2016) and Siddeswari et al., (2016) , in which there were 60.38%&60% cases respectively, as there is decrease in CD4 cell count there is increase in opportunistic infections. In our study, age group had a significant association. CD4 cell count of ≤200 cells/l was significantly more in older age groups 74(71.84%) as compared to younger age group, which was also echoed in study done by Ketki Jangid et al., (2015) 63%. This is in accordance with the fact that the CD4 cell count decreases with the advancing age.
A higher number patient with Extrapulmonary TB 98(61.25%) was observed to have CD4 cell count ≤200 cells/µl as compared to the Pulmonary TB cases 73(56.58%). Kavya et al., (2014) reported 58.46% EPTB and 41.64% of PTB in the range CD4 cell count ≤200 cells/µl which was comparable to our results. The direct correlation of all kind of tuberculosis and CD4 cell count depletion was observed. It was also observed that as the age advances the immunity tapers down. Also, the co infection was seen more in male patients, so it is suggested increase monitoring and nutritional support as adjunct therapy should also be considered. Extra-pulmonary and sputum negative pulmonary HIV-TB patients outnumbered the sputum positive HIV-TB patients, which concludes that a newer & better diagnostic test is required.
